Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 23, No. 1, 2005   

Free Abstract     Article (References)     Article (PDF 343 KB)     

Original Paper

Should Nonalcoholic Fatty Liver Disease Be Renamed?
Paola Loriaa, Amedeo Lonardob, Nicola Carullia

aDipartimento di Medicina Interna Università di Modena e Reggio Emilia, and
bU.O. Medicina Interna e Gastroenterologia - Ospedale Civile di Modena, Modena, Italy

Address of Corresponding Author

Dig Dis 2005;23:72-82 (DOI: 10.1159/000084728)


 goto top of page Key Words

  • Definitions
  • Fibrosis
  • Hepatic steatosis
  • Insulin resistance
  • Leptin
  • Metabolic syndrome
  • NASH
  • Pathogenesis

 goto top of page Abstract

Background:None of the synonyms of nonalcoholic fatty liver disease (NAFLD) include clinical correlates nor do they mention insulin resistance, a recognized determinant of the etiopathogenesis and natural history of NAFLD. Method: The literature concerning the pathogenesis and definition of NAFLD is reviewed Results: The reasons why NAFLD should be renamed are: (a) clinically meaningful hepatic steatosis could be present at less than 5% triglyceride hepatic content; (b) steatosis is usually no longer observed in the most advanced forms of NAFLD ('cryptogenic cirrhosis'); (c) the concurrence of metabolic derangements could be more important than alcohol in the pathogenesis of alcoholic liver disease; (d) a concurrent metabolic etiology might worsen the course of chronic HCV and autoimmune hepatitis; (e) in NAFLD the liver is a target organ of the metabolic syndrome, a systemic subclinical inflammatory state. Conclusion: The introduction of a positive criterion also mentioned in its definition would benefit the diagnosis of NAFLD and of steatohepatitis observed in the setting of other liver diseases, help to estimate the risk of its progression and aid the treatment of metabolic (fatty) liver disorders. There is a compelling need for an experts' agreement on a new definition of insulin resistance/metabolic-related liver disease.

Copyright © 2005 S. Karger AG, Basel


 goto top of page Author Contacts

Paola Loria, MD
Università degli Studi di Modena-Azienda Ospedaliera Policlinico
Via del Pozzo, 71
IT-41100 Modena (Italy)
Tel. +39 059 4222431, Fax +39 059 363114, E-Mail loria.paola@unimore.it


 goto top of page Article Information

Number of Print Pages : 11
Number of Figures : 5, Number of Tables : 3, Number of References : 140

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 15920328)
Download Citation
Cited In



This journal is part of the third subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

Case Reports in Gastroenterology


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2010 S. Karger AG, Basel